Skip to main content
. 2021 Aug 21;74(5):2452–2466. doi: 10.1002/hep.31995

TABLE 2.

Logistic Regression Analysis for the Prediction of NASH in 213 Patients With Biopsy‐Proven NAFLD

Factor Univariate Analysis Multivariate Analysis
OR 95% CI P Value OR 95% CI P Value
Age (years) Per year 1.057 1.031‐1.083 <0.05 1.042 1.008‐1.078 <0.05
Sex (M/F) 0.8 0.454‐1.409 N.S.
Body mass index (kg/m2) per 1 kg/m2 1.018 0.961‐1.077 N.S.
AST (U/L) per 10 U/L 1.3 1.162‐1.454 <0.05 N.S.
ALT (U/L) per 10 U/L 1.071 1.009‐1.136 <0.05 N.S.
GGT (U/L) per 10 U/L 1.021 0.983‐1.060 N.S.
ALP (U/L) per 40 U/L 1.027 0.925‐1.141 N.S.
Triglyceride (mg/dL) per 10 mg/dL 1.019 0.985‐1.054 N.S.
LDL‐C (mg/dL) per 10 mg/dL 0.951 0.873‐1.036 N.S.
Fasting blood sugar (mg/dL) per 10 mg/dL 1.057 0.989‐1.129 N.S.
HbA1c (%) per 1 % 1.219 0.970‐1.531 N.S.
AFP (ng/mL) per 1 ng/mL 1.318 1.147‐1.514 <0.05 N.S.
Albumin (g/dL) per 1 g/dL 0.259 0.103‐0.653 <0.05 N.S.
Platelet count (×104/μL) per 1X 104/μL 0.88 0.837‐0.926 <0.05 0.928 0.875‐0.984 <0.05
TSP‐2 (ng/mL) per 1 ng/mL 1.039 1.026‐1.052 <0.05 1.03 1.016‐1.045 <0.05

Abbreviations: AFP, alpha‐fetoprotein; F, female; GGT, γ‐glutamyl transpeptidase; LDL‐C, low density lipoprotein cholesterol; M, male; N.S., not significant.